Mirae Asset Global ETFs Holdings’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
21,459
-590
-3% -$8.42K ﹤0.01% 2371
2026
Q1
$370K Buy
22,049
+258
+1% +$4.62K ﹤0.01% 2044
2025
Q4
$349K Sell
21,791
-250
-1% -$3.72K ﹤0.01% 2075
2025
Q3
$272K Sell
22,041
-3,691
-14% -$43.3K ﹤0.01% 2160
2025
Q2
$296K Sell
25,732
-2,161
-8% -$25.6K ﹤0.01% 2075
2025
Q1
$418K Buy
27,893
+1,170
+4% +$19.6K ﹤0.01% 1959
2024
Q4
$463K Buy
26,723
+960
+4% +$18.5K ﹤0.01% 1953
2024
Q3
$477K Buy
25,763
+1,358
+6% +$27.3K ﹤0.01% 1935
2024
Q2
$495K Buy
+24,405
New +$432K ﹤0.01% 1833

Other funds holding CLB

Mirae Asset Global ETFs Holdings's CLB Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Core Laboratories (CLB) stake by 2.7% in Q2 2026, selling an estimated $8.42K and leaving 21,459 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #2371.

Mirae Asset Global ETFs Holdings first reported a position in CLB in Q2 2024 and has held it in 9 quarters since. The position peaked at $495K in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 21,459 shares of Core Laboratories worth $250K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 590 Core Laboratories shares in Q2 2026, an estimated $8.42K.
  • Core Laboratories made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2371 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Core Laboratories in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Core Laboratories position peaked at $495K in Q2 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.